Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group

Rationale for the use of alternating non-cross-resistant chemotherapy.

1982 • 545 citations

Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease

1982 • 212 citations

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

1987 • 155 citations

Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

1987 • 146 citations

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.

1988 • 131 citations

The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer

1988 • 44 citations

Second line chemotherapy in small cell lung cancer

1989 • 28 citations

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer

1989 • 15 citations

Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study

1992 • 11 citations

Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.

1989 • 10 citations